Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ceapro Inc
V.CZO
Chemicals
Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human...
, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CZO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(1996)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Jan 09, 2024 8:08am
RE:RE:RE:fossi doesn't want people to talk about it.
Yes, we first need to get past this sham of a merger with a resounding NO on both CZO and AEZS shareholder votes. Then we need to stick to the original plan to vote him off the board in June and put
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jan 09, 2024 7:24am
RE:AEZS's Diagnostic Test:
Hopefully there will NR on this for the merger approval' As the partner will probably be a smaller company like Pharmanovie in Europe I don't expect they can afford the trials remboursement
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 09, 2024 7:07am
AEZS's Diagnostic Test:
AEZS received US$24 million upfront from Strongbridge, and was to receive US$5 million for pediatric approval. Pediatric approval could happen this year. Adding an assumed ~US$10 million for the
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 08, 2024 7:38pm
RE:RE:RE:fossi doesn't want people to talk about it.
Everestbaker, "Agree with you completely Fossi." You agree with fossi who less than nine months ago applauded CZO's step-wise plan for PGX as the ""right"
...more
(15)
•••
Everestbaker
X
View Profile
View Bullboard History
Comment by
Everestbaker
on Jan 08, 2024 7:36pm
RE:approval of at least 66-2/3 per cent of the votes
I'm curious how AEZS shareholders would vote as well. As for us at CZO, Gagnon got saved by Oats last time and let's see if that will be enough time around IF they still decide to support him.
...more
(15)
•••
Everestbaker
X
View Profile
View Bullboard History
Comment by
Everestbaker
on Jan 08, 2024 7:21pm
RE:RE:fossi doesn't want people to talk about it.
Like I posted, PoF/Digitel is back to spamming the board - I guess two can play a game and start replying to their own posts. Anyways, most of us long shareholders with accounts here know his/her
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 08, 2024 4:28pm
Up against two year high
The S&P Biotech ETF is now up against its two year high after its best two months in history. It precipitously fell to this level with inflation fears. A precipitous move up next? The question
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 08, 2024 3:55pm
RE:RE:RE:RE:S&P Biotech ETF
Best two months for biotech ever... Gilles purchase of AEZS could be epic - right at the bottom before the historic move. @LifeSciVC
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 08, 2024 3:26pm
RE:RE:RE:S&P Biotech ETF
People here think Gilles controls the US Federal Reserve and interest rates. It's not true. $XBI is just an Inverse derivative of Fed Rate Expectations
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 08, 2024 3:22pm
RE:RE:S&P Biotech ETF
That was quick... New 52-week high for the S&P Biotech ETF. One thing the merger should do is put CZO on the radar. It gets CZO off the TSX-V. It gets it on the NASDAQ and TSX. HC Wainwright
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jan 08, 2024 2:46pm
RE:S&P Biotech ETF
43% move in biotech of the bottom about two months ago. Then people start looking at what hasn't moved yet... @Gantosj
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 08, 2024 2:35pm
S&P Biotech ETF
is up ~4.4% already this year and is almost through it's 52-week high. AEZS was about double the price it currently is when the S&P Biotech ETF was trading around its current price in Feb. of
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jan 08, 2024 1:57pm
RE:Curious about the investigation
I have no news on this@ given us lawyers ability to jump at any opportunity I would not be surprised the claims go nowhere@
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jan 08, 2024 1:57pm
RE:Curious about the investigation
I have no news on this' given us lawyers ability to jump at any opportunity I would not be surprised the claims go nowhere
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jan 08, 2024 1:34pm
RE:If you Vote yes
"I have to agree. Gilles should buy significant amount of shares or get compensated solely on value creation in order to demonstrate real commitment and not just draining of shareholders money
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed